+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Radiation Dose Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4851984
  • Report
  • Region: Global
  • 225 pages
  • Transparency Market Research
1 of 2

Radiation Dose Management Market - Overview

This report on the radiation dose management market analyzes the current and future scenario of the global market. The global radiation dose management market report comprises a detailed elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the country’s market with respect to the segments based on products and services, modality, application and end user. An elaborated qualitative analysis of drivers and trends has been provided in the market overview section. This section also provides market attractiveness analysis in terms of country, thus presenting a thorough analysis of the overall competitive scenario in the global radiation dose management market.

Based on products and services, the global radiation dose management market has been classified into software and services. The market segments have been analyzed based on the different radiation dose management solution and tools that are available in the market and widely utilized by healthcare organizations. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on modality, the market has been segregated into computed tomography, radiography and mammography, fluoroscopy and interventional imaging, nuclear medicine scans, and others. In term of application, the market has been bifurcated into oncology, cardiology, orthopedic, and others. The market segments have been extensively analyzed based on imaging system used in time of diagnosis, which type of disease are diagnosed, and imaging with radiation dose management and medical reimbursements. The market size and forecast in terms of value (US$ Mn) for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year. Based on end-user, the radiation dose management market has been split into hospitals, ambulatory care settings, research organizations, and others. The end-user segmentation has been done on the basis of purchase of radiation drug management system and solution, which is used for imaging diagnosis.

In terms of geography, the global radiation dose management market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

The report also profiles major players in the global radiation dose management market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Key players operating in the global radiation dose management market include Landauer, Inc., Spectra AB, Agfa-Gevaert N.V., INFINITT Healthcare Co. Ltd., Bayer AG, PACSHealth, LLC, Koninklijke Philips N.V., GE Healthcare, Thermo Fisher Scientific, Fujifilm Holdings Corporation, and QAELUM NV.

Note: Product cover images may vary from those shown
2 of 2
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary : Global Radiation Dose Management Market

Chapter 4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.1.2. Industry Evolution/Developments
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.3. Opportunities
4.4. Key Trends

Chapter 5. Global Radiation Dose Management Market Analysis and Forecast, by Product and Services
5.1. Key Findings/Developments
5.2. Introduction & Definition
5.3. Market Value Forecast, by Product and Services, 2018-2026
5.3.1. Software
5.3.1.1. Integrated Solution
5.3.1.2. Standalone Solution
5.3.2. Services
5.4. Market Attractiveness, by Products and Services

Chapter 6. Global Radiation Dose Management Market Analysis and Forecast, by Modality
6.1. Key Findings/Developments
6.2. Introduction & Definition
6.3. Market Value Forecast, by Modality, 2016-2026
6.3.1. Computed Tomography
6.3.2. Radiography and Mammography
6.3.3. Fluoroscopy and Interventional Imaging
6.3.4. Nuclear Medicine Scans
6.3.5. Others
6.4. Market Attractiveness, by Modality

Chapter 7. Global Radiation Dose Management Market Analysis and Forecast, by Application
7.1. Key Findings/Developments
7.2. Introduction & Definition
7.3. Market Value Forecast, by Application, 2016-2026
7.3.1. Oncology
7.3.2. Cardiology
7.3.3. Orthopedic
7.3.4. Others
7.4. Market Attractiveness, by Application

Chapter 8. Global Radiation Dose Management Market Analysis and Forecast, by End-user
8.1. Key Findings/Developments
8.2. Introduction & Definition
8.3. Market Value Forecast, by End-user, 2016-2026
8.3.1. Hospitals
8.3.2. Ambulatory Care Settings
8.3.3. Research Organizations
8.3.4. Others
8.4. Market Attractiveness, by End-user

Chapter 9. Global Radiation Dose Management Market Analysis and Forecast, by Geography/Region
9.1. Geographical Representation
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
9.4. Key Trends

Chapter 10. North America Radiation Dose Management Market Analysis and Forecast
10.1. Market Value Forecast, by Country , 2018-2026
10.1.1. U.S.
10.1.2. Canada
10.2. Market Value Forecast, by Product and Services, 2018-2026
10.2.1. Software
10.2.1.1. Integrated Solution
10.2.1.2. Standalone Solution
10.2.2. Services
10.3. Market Value Forecast, by Modality, 2018-2026
10.3.1. Computed Tomography
10.3.2. Radiography and Mammography
10.3.3. Fluoroscopy and Interventional Imaging
10.3.4. Nuclear Medicine Scans
10.3.5. Others
10.4. Market Value Forecast, by Application, 2018-2026
10.4.1. Oncology
10.4.2. Cardiology
10.4.3. Orthopedic
10.4.4. Others
10.5. Market Value Forecast, by End-user, 2018-2026
10.5.1. Hospitals
10.5.2. Ambulatory Care Settings
10.5.3. Research Organizations
10.5.4. Others
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Product and Services
10.6.3. By Modality
10.6.4. By Application
10.6.5. By End-user

Chapter 11. Europe Radiation Dose Management Market Analysis and Forecast
11.1. Market Value Forecast, by Country , 2018-2026
11.1.1. Germany
11.1.2. France
11.1.3. U.K.
11.1.4. Spain
11.1.5. Italy
11.1.6. Rest of Europe
11.2. Market Value Forecast, by Product and Services, 2018-2026
11.2.1. Software
11.2.1.1. Integrated Solution
11.2.1.2. Standalone Solution
11.2.2. Services
11.3. Market Value Forecast, by Modality, 2018-2026
11.3.1. Computed Tomography
11.3.2. Radiography and Mammography
11.3.3. Fluoroscopy and Interventional Imaging
11.3.4. Nuclear Medicine Scans
11.3.5. Others
11.4. Market Value Forecast, by Application, 2018-2026
11.4.1. Oncology
11.4.2. Cardiology
11.4.3. Orthopedic
11.4.4. Others
11.5. Market Value Forecast, by End-user, 2018-2026
11.5.1. Hospitals
11.5.2. Ambulatory Care Settings
11.5.3. Research Organizations
11.5.4. Others
11.6. Market Attractiveness Analysis
11.6.1. By Country
11.6.2. By Product and Services
11.6.3. By Modality
11.6.4. By Application
11.6.5. By End-user

Chapter 12. Asia Pacific Radiation Dose Management Market Analysis and Forecast
12.1. Market Value Forecast, by Country , 2018-2026
12.1.1. China
12.1.2. Japan
12.1.3. India
12.1.4. Australia & New Zealand
12.1.5. Rest of APAC
12.2. Market Value Forecast, by Product and Services, 2018-2026
12.2.1. Software
12.2.1.1. Integrated Solution
12.2.1.2. Standalone Solution
12.2.2. Services
12.3. Market Value Forecast, by Modality, 2018-2026
12.3.1. Computed Tomography
12.3.2. Radiography and Mammography
12.3.3. Fluoroscopy and Interventional Imaging
12.3.4. Nuclear Medicine Scans
12.3.5. Others
12.4. Market Value Forecast, by Application, 2018-2026
12.4.1. Oncology
12.4.2. Cardiology
12.4.3. Orthopedic
12.4.4. Others
12.5. Market Value Forecast, by End-user, 2018-2026
12.5.1. Hospitals
12.5.2. Ambulatory Care Settings
12.5.3. Research Organizations
12.5.4. Others
12.6. Market Attractiveness Analysis
12.6.1. By Country
12.6.2. By Product and Services
12.6.3. By Modality
12.6.4. By Application
12.6.5. By End-user

Chapter 13. Latin America Radiation Dose Management Market Analysis and Forecast
13.1. Market Value Forecast, by Country, 2018-2026
13.1.1. Brazil
13.1.2. Mexico
13.1.3. Rest of LATAM
13.2. Market Value Forecast, by Product and Services, 2018-2026
13.2.1. Software
13.2.1.1. Integrated Solution
13.2.1.2. Standalone Solution
13.2.2. Services
13.3. Market Value Forecast, by Modality, 2018-2026
13.3.1. Computed Tomography
13.3.2. Radiography and Mammography
13.3.3. Fluoroscopy and Interventional Imaging
13.3.4. Nuclear Medicine Scans
13.3.5. Others
13.4. Market Value Forecast, by Application, 2018-2026
13.4.1. Oncology
13.4.2. Cardiology
13.4.3. Orthopedic
13.4.4. Others
13.5. Market Value Forecast, by End-user, 2018-2026
13.5.1. Hospitals
13.5.2. Ambulatory Care Settings
13.5.3. Research Organizations
13.5.4. Others
13.6. Market Attractiveness Analysis
13.6.1. By Country
13.6.2. By Product and Services
13.6.3. By Modality
13.6.4. By Application
13.6.5. By End-user

Chapter 14. Middle East & Africa Radiation Dose Management Market Analysis and Forecast
14.1. Market Value Forecast, by Country , 2018-2026
14.1.1. GCC Countries
14.1.2. South Africa
14.1.3. Israel
14.1.4. Rest of MEA
14.2. Market Value Forecast, by Product and Services, 2018-2026
14.2.1. Software
14.2.1.1. Integrated Solution
14.2.1.2. Standalone Solution
14.2.2. Services
14.3. Market Value Forecast, by Modality, 2018-2026
14.3.1. Computed Tomography
14.3.2. Radiography and Mammography
14.3.3. Fluoroscopy and Interventional Imaging
14.3.4. Nuclear Medicine Scans
14.3.5. Others
14.4. Market Value Forecast, by Application, 2018-2026
14.4.1. Oncology
14.4.2. Cardiology
14.4.3. Orthopedic
14.4.4. Others
14.5. Market Value Forecast, by End-user, 2018-2026
14.5.1. Hospitals
14.5.2. Ambulatory Care Settings
14.5.3. Research Organizations
14.5.4. Others
14.6. Market Attractiveness Analysis
14.6.1. By Country
14.6.2. By Product and Services
14.6.3. By Modality
14.6.4. By Application
14.6.5. By End-user

Chapter 15. Competition Landscape
15.1. Competition Matrix
15.1.1. Landauer, Inc.
15.1.2. Bayer Healthcare AG
15.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
15.2.1. Landauer, Inc.
15.2.1.1. Company Details
15.2.1.2. Company Description
15.2.1.3. Business Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Financial Analysis
15.2.1.6. Strategic Overview
15.2.2. Agfa-Gevaert N.V.
15.2.2.1. Company Details
15.2.2.2. Company Description
15.2.2.3. Business Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Sectra AB
15.2.3.1. Company Details
15.2.3.2. Company Description
15.2.3.3. Business Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. INFINITT Healthcare Co. Ltd.
15.2.4.1. Company Details
15.2.4.2. Company Description
15.2.4.3. Business Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Bayer Healthcare AG
15.2.5.1. Company Details
15.2.5.2. Company Description
15.2.5.3. Business Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Financial Analysis
15.2.5.6. Strategic Overview
15.2.6. PACSHealth, LLC
15.2.6.1. Company Details
15.2.6.2. Company Description
15.2.6.3. Business Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Financial Analysis
15.2.6.6. Strategic Overview
15.2.7. Koninklijke Philips N.V.
15.2.7.1. Company Details
15.2.7.2. Company Description
15.2.7.3. Business Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Financial Analysis
15.2.7.6. Strategic Overview
15.2.8. GE Healthcare
15.2.8.1. Company Details
15.2.8.2. Company Description
15.2.8.3. Business Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Financial Analysis
15.2.8.6. Strategic Overview
15.2.9. Thermo Fisher Scientific
15.2.9.1. Company Details
15.2.9.2. Company Description
15.2.9.3. Business Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Strategic Overview
15.2.10. Medsquare SAS
15.2.10.1. Company Details
15.2.10.2. Company Description
15.2.10.3. Business Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Strategic Overview
15.2.11. Siemens AG
15.2.11.1. Company Details
15.2.11.2. Company Description
15.2.11.3. Business Overview
15.2.11.4. SWOT Analysis
15.2.11.5. Strategic Overview
15.2.12. Fujifilm Holdings Corporation
15.2.12.1. Company Details
15.2.12.2. Company Description
15.2.12.3. Business Overview
15.2.12.4. SWOT Analysis
15.2.12.5. Strategic Overview
15.2.13. QAELUM NV
15.2.13.1. Company Details
15.2.13.2. Company Description
15.2.13.3. Business Overview
15.2.13.4. SWOT Analysis
15.2.13.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll